Procyrion

company

About

Procyrion develops technology solutions and offers a catheter-based circulatory support technologies.

  • 1 - 10

Details

Last Funding Type
Series C
Last Funding Money Raised
$16M
Industries
Health Care,Medical,Medical Device
Founded date
Jan 1, 2005
Number Of Employee
1 - 10
Operating Status
Active

Procyrion develops technology solutions and offers a catheter-based circulatory support technologies. One in five adults over the age of 40 will develop heart failure in his or her lifetime. For the sickest patients, only 1% receive treatment annually due to scarcity, cost, and high risk of current solutions.

Procyrion, has developed a solution: Aortix is a circulatory support pump implanted without surgery. Thinner than a #2 pencil, a cardiologist can implant Aortix through a catheter in the leg, deploying it between the heart and the kidneys to unload the failing heart and perfuse vital organs. This first-in-class device allows the heart to rest and heal while correcting the fluid imbalance.

The company was founded in 2005 and is based in Houston, Texas.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$16M
Procyrion has raised a total of $16M in funding over 2 rounds. Their latest funding was raised on Jan 31, 2018 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 31, 2018 Series C $16M 1 Aquinas Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Procyrion is funded by 1 investors. Aquinas are the most recent investors.
Investor Name Lead Investor Funding Round
Aquinas Yes Series C